Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03244384
Brief Title: Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer (AMBASSADOR)

First Submitted : August 7, 2017
First Submitted that Met QC Criteria : August 8, 2017
First Posted : August 9, 2017

Last Update Submitted that Met QC Criteria : July 31, 2021
Last Update Posted : August 3, 2021 (Estimate)